Navigation Links
Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
Date:9/10/2007

Actel's ProASIC3 Solutions Offer Low-power Operation and Protect Valuable

Intellectual Property for Portable Patient Monitoring Systems

MOUNTAIN VIEW, Calif., Sept. 10 /PRNewswire-FirstCall/ -- Demonstrating the success of its low-power and power-efficient programmable technologies, Actel Corporation today announced that Mindray Medical International Limited (NYSE: MR), China's leading developer and manufacturer of medical devices, has chosen Actel's flash-based ProASIC3 field-programmable gate arrays (FPGAs) for implementation in its portable patient monitoring systems. Selected for the low-power, enhanced security, performance, and firm-error immunity it offers, the 60,000-gate ProASIC3 A3P060 is being deployed to provide the highest possible levels of secure patient data management.

Following the successful deployment of Actel's ProASIC3, Mindray plans to continue to leverage Actel flash-based FPGAs in next-generation products, including other patient monitoring devices, diagnostic laboratory instruments and ultrasound imaging systems. Actel expects that IGLOO, its award-winning, low-power, flash-based FPGA, will be implemented in Mindray's next product release. Mindray also plans to incorporate Actel's ARM processor-enabled, flash-based FPGAs into their medical devices.

"This partnership helps advance our portable patient monitor line by bringing us the reliable low-power and security functionalities needed to eliminate power surges and errors associated with SRAM-based solutions," said Mr. Li Yao, Mindray's manager of R&D. "Actel's flash-based solutions, such as the [A3P060] ProASIC3, have leading power, security and radiation resistance capabilities that far exceed alternative FPGA technologies."

Mindray's comprehensive portfolio of patient monitoring systems ranges in security complexity from those that contain three to four security modules to those that contain 12. Each module is designed to monitor and control the security of one element of a patient's data, such as heart rate and blood pressure etc

"Mindray's selection of our ProASIC3 devices in its industry-leading, high-quality portable patient monitoring systems underscores the advantages that flash-based FPGAs provide for today's portable applications," said Rick Lain, director of sales, Asia Pacific at Actel. "Providing unprecedented low power, small footprint and security in a single chip, Actel's feature-rich FPGAs uniquely possess features highly sought after by the ever-growing international community of portable electronics designers."

About Mindray

Mindray Medical International Limited is a leading developer, manufacturer and marketer of medical devices in China with a significant and growing presence worldwide. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring devices, diagnostic laboratory instruments, and ultrasound imaging systems. Mindray is headquartered in Shenzhen, China, and has 29 local sales and service offices in China, as well as sales and service offices in Boston, Istanbul, London, Mumbai, Seattle and Vancouver. For more information, please visit http://www.mindray.com.

About Actel

Attacking power consumption from both the chip and the system levels, Actel power-smart programmable solutions enable power-efficient design. The company is the leader in single-chip FPGA solutions. Founded in 1985, Actel employs more than 550 people worldwide. The Company is traded on the Nasdaq National Market under the symbol ACTL. For more information, visit http://www.actel.com.

The Actel name and logo are registered trademarks of Actel Corporation. The Actel IGLOO and Actel Fusion names and logos are trademarks of Actel Corporation. All other trademarks and servicemarks are the property of their respective owners.


'/>"/>
SOURCE Actel Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. United States Department of Defense Selects Ichor Medical Systems to Develop Biodefense Vaccine
2. Relieve hot flashes
3. Antidepressant Helps Relieve Hot Flashes
4. Insight for Hot Flashes In Postmenopausal Women
5. Long Term Mediation Not Advisable To Treat Hot Flashes
6. Women With Severe Hot Flashes May Have Increased Chronic Sleep Problem
7. Hot Flashes Could Be Minimized By Rhubarb Extract
8. Black Cohosh Does Not Treat Hot Flashes
9. Blood Tests That Promise to Predict Heart Attacks Turn Out to Be a Flash in the Pan
10. Free Condoms in a Flashy Wrapper
11. Hot Flashes in Women Linked to High Blood Pressure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 19, 2017 , ... Remote Medical Technologies (RMT), the leader ... with their iMedHD2™ Portable Teleultrasound System. Compatible with any ultrasound ... HD, dynamic, streaming ultrasound images and video to one or more distant locations ...
(Date:1/19/2017)... City, Utah (PRWEB) , ... January 19, 2017 ... ... Film Festival in a medical capacity this year. Drs. Alexander Paziotopoulos, Andrew Petersen ... to provide a condensed version of the clinic’s leading recovery program. , ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... by the American Board of Dermatology and fellowship trained Mohs and cosmetic surgeon. ... Institutes of Health, Dr. Li completed his internship in internal medicine at the ...
(Date:1/19/2017)... ... January 19, 2017 , ... Bio-Optronics ... provides a modern CTMS workflow designed to seamlessly integrate and streamline the way ... to a single page, maximizing usability and improving efficiency significantly for users – ...
(Date:1/19/2017)... San Antonio, Texas (PRWEB) , ... January 19, 2017 , ... ... entering the GenCure Tissue Donation Awareness Scholarship competition., The winner will earn a $1,000 ... media accounts. The competition begins Feb. 1, and the deadline is May 31, with ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... YORK , Jan. 19, 2017 This ... the current and future scenario of the global market. ... rising opioid consumption. Severe chronic constipation is a major ... to traditional laxatives. Hence, novel targeted therapy has been ... OIC sufferers, launch of targeted medicines, and growing awareness ...
(Date:1/19/2017)... January 19, 2017 According to a study ... is set to witness a CAGR of 6.5% during the forecast ... will continue to be the leading market for cryotherapy globally ... ... emphasizing on ensuring affordable and adequate supply of gas in order ...
(Date:1/19/2017)... , Jan. 19, 2017  Sensus Healthcare, Inc. ... company specializing in the treatment of non-melanoma skin ... with superficial radiation therapy, today announced that it ... 2016 financial results on Thursday, February 2, 2017 after ... hold a conference call with the investment community ...
Breaking Medicine Technology: